Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study-Reference-Cited by-同舟云学术

Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study

Published:2017-03-28 Issue:10 Volume:116 Page:1287-1293
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Phelps David L,Borley Jane V,Flower Kirsty J,Dina Roberto,Darb-Esfahani Silvia,Braicu Ioana,Sehouli Jalid,Fotopoulou Christina,Wilhelm-Benartzi Charlotte S,Gabra Hani,Yazbek Joseph,Chatterjee Jayanta,Ip Jacey,Khan Harun,Likos-Corbett Marina-Therese,Brown Robert,Ghaem-Maghami Sadaf

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201783.pdf

Reference31 articles.

1. Agarwal R, Kaye SB (2003) Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 3 (7): 502–516.

2. Al-Sadi R, Ye D, Dokladny K, Ma TY (2008) Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol 180 (8): 5653–5661.

3. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong SM, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Marie SK, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih LM, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang TL, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz LA Jr . (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6 (224): 224ra24.

4. Borley J, Wilhelm-Benartzi C, Brown R, Ghaem-Maghami S (2012) Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review. Br J Cancer 107 (7): 1069–1074.

5. Chan JY, Takeda M, Briggs LE, Graham ML, Lu JT, Horikoshi N, Weinberg EO, Aoki H, Sato N, Chien KR, Kasahara H (2008) Identification of cardiac-specific myosin light chain kinase. Circ Res 102 (5): 571–580.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis;BMC Women's Health;2024-03-15

2. Aberrant DNA methylation signatures in gynecological malignancies;Epigenetics in Human Disease;2024

3. Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review;International Journal of Gynecologic Cancer;2023-08-29

4. Molecular and phenotypic characteristics influencing the degree of cytoreduction in high‐grade serous ovarian carcinomas;Cancer Medicine;2023-05-16

5. Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: The evolution of a “pelvic” surgeon;Gynecologic Oncology;2023-03